COMMUNIQUÉS West-GlobeNewswire

Affidea accélère sa croissance au Royaume-Uni en signant un partenariat stratégique avec LIPS Healthcare
24/07/2026
LONDRES, 24 juill. 2026 (GLOBE NEWSWIRE) -- Affidea, prestataire paneuropéen de cliniques de proximité, de diagnostics de pointe et de services de santé privés spécialisés, annonce aujourd’hui la signature d’un [...]
HorseFil Official Launch 2026 Effective Men's Energy and Vitality Gummies Highlights Ingredient, Supplement Facts Available in USA
24/07/2026
HorseFil is a men's dietary supplement formulated with a blend of carefully selected botanical extracts, amino acids, vitamins, and minerals designed to support men's overall wellness. According to the manufacturer, the [...]
Nordic Naturals Releases Expert Insights on Why Omega-3s Should Be on Back-to-School Checklists
24/07/2026
Company highlights the important role omega-3s play in children's brain development and cognitive function as they head back to the classroom Watsonville, CA, July 24, 2026 (GLOBE NEWSWIRE) -- Nordic Naturals, the #1 [...]
HorseFil Publishes Full Milligram Amounts for All Seven Ingredients: Tongkat Ali 200 mg, Serving Directions, and Safety Information for 2026
25/07/2026
HorseFil's Tongkat Ali, Maca Root, Ashwagandha, and Horny Goat Weed Amounts Per Gummy Ogden, UT, July 24, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the Food and Drug Administration. HorseFil [...]
Pelthos Therapeutics Announces 2026 Annual Meeting of Stockholders
24/07/2026
DURHAM, N.C., July 24, 2026 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS) (the “Company” or “Pelthos”) today announced that it will hold its 2026 Annual Meeting of Stockholders virtually on Tuesday [...]
NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026
24/07/2026
ROCKVILLE, Md., July 24, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines for areas of significant [...]
Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Listed Securities Deficiency
24/07/2026
Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Listed Securities Deficiency IRVINE, California – July 24, 2026 (GlobeNewswire) – Mdxhealth SA (NASDAQ: MDXH) (the “Company” or “ [...]
ColestZen Publishes Ingredient Facts for Its 18-Ingredient Supplement Formula: Serving Directions and Safety Information for 2026
24/07/2026
ColestZen's Bitter Melon, Cinnamon, Licorice, and Gymnema Sylvestre Ingredient Forms Tallmadge, OH, July 24, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the Food and Drug Administration. [...]
Robotic Radical Prostatectomy Comes Up ‘Short’ in CAPTAIN Trial
24/07/2026
– Whole-gland TULSA ablation demonstrates statistically significant superior penile length preservation compared to robotic RP at 1 month – TORONTO, July 24, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF [...]
Dr. Ekta Pandya Named Fellow of Pierre Fauchard Academy, Recognized for Leadership in Dentistry and Children's Oral Health
24/07/2026
Pierre Fauchard Academy Fellow recognized for leadership in dentistry, education, pediatric oral health, and community service Dr. Ekta Pandya, newly named Pierre Fauchard Academy Fellow. NEW PALTZ, N.Y., July 24, 2026 [...]
Ernexa Therapeutics CEO Corner Emphasizes How ERNA-101 Could Help Unlock the Next Generation of Combination Cancer Therapies
24/07/2026
CEO Discusses Why the Future of Cancer Treatment May Belong to Combination Approaches and How ERNA-101 Was Designed to Turn Immunologically "Cold" Tumors Into Targets for the Immune System Video Showcases Differentiated [...]
Surgery Partners Announces Entry Into Agreement to Sell Ownership Interests in Idaho Falls Facilities to Intermountain Health; Reaffirms Guidance, Excluding Impact of Transaction
24/07/2026
Represents significant milestone in the Company’s ongoing portfolio optimization efforts BRENTWOOD, Tenn., July 24, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a [...]
hear.com Honored as Gold Stevie® Award Winner in 2026 Stevie Awards for Technology Excellence
24/07/2026
Award recognizes Horizon IX hearing aids and Clinic-in-a-Box® tele-audiology for expanding access to hearing care nationwide MIAMI, July 24, 2026 (GLOBE NEWSWIRE) -- hear.com , a global innovator in hearing care, has [...]
NEZGLYAL® (leriglitazone) receives a positive CHMP opinion for the treatment of cerebral Adrenoleukodystrophy (cALD), a rare neurodegenerative disease
24/07/2026
Recommendation based on NEXUS data; Minoryx and Neuraxpharm expect European Commission approval by the end of this quarter BARCELONA, Spain and DÜSSELDORF, Germany, July 24, 2026 (GLOBE NEWSWIRE) -- Minoryx Therapeutics [...]
Autonomix Medical Demonstrates Renal Nerve Sensing and Neural Activity Change in Preclinical Study
24/07/2026
Data demonstrate the ability to detect, localize and confirm changes in renal neural activity, supporting continued development of physiology-guided renal denervation THE WOODLANDS, TX, July 24, 2026 (GLOBE NEWSWIRE [...]
Magnendo Secures $18M Series A Financing to Transform Endovascular Access for Stroke Intervention
24/07/2026
MIT spinout to accelerate product development and first-in-human studies of its magnetic robotic navigation platform designed to dramatically improve the speed and reliability of neuro-endovascular procedures NEWTON, [...]
NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
24/07/2026
- Positive CHMP opinion supports potential commercialization of obicetrapib monotherapy and obicetrapib/ezetimibe fixed-dose combination in Europe - - Recommendation based on positive Phase 3 BROADWAY, BROOKLYN, and [...]
Amwell® to report second quarter 2026 operating results
24/07/2026
BOSTON, July 24, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report second quarter 2026 operating results [...]
Immutep Announces Abstract Accepted for Presentation at the European Society for Medical Oncology (ESMO) Congress 2026
24/07/2026
SYDNEY, AUSTRALIA, July 24, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announced [...]

Pages

Other news

Test 2

22/10/2026

Lorem ipsum

Test 1

22/10/2026

Lorem upsum